Literature DB >> 17389673

Proposal for a new tool to evaluate drug interaction cases.

John R Horn1, Philip D Hansten, Lingtak-Neander Chan.   

Abstract

The assessment of causation for a potential drug interaction requires thoughtful consideration of the properties of both the object and precipitant drugs, patient-specific factors, and the possible contribution of other drugs that the patient may be taking. The Naranjo nomogram was designed to evaluate single-drug adverse events, not drug-drug interactions. Several of the questions on the Naranjo nomogram do not apply to potential drug-drug interactions, while others do not specify object or precipitant drug. Nevertheless, it has been inappropriately used to evaluate drug-drug interactions. The Drug Interaction Probability Scale (DIPS) was developed to provide a guide to evaluating drug interaction causation in a specific patient. It is intended to be used to assist practitioners in the assessment of drug interaction-induced adverse outcomes. The DIPS uses a series of questions relating to the potential drug interaction to estimate a probability score. An accurate assessment using the DIPS requires knowledge of the pharmacologic properties of both the object and precipitant drugs. Inadequate knowledge of either the drugs involved or the basic mechanisms of interaction will be a limitation for some users. The DIPS can also serve as a guide in the preparation of articles describing case reports of drug interactions, as well as in the evaluation of published case reports.

Entities:  

Mesh:

Year:  2007        PMID: 17389673     DOI: 10.1345/aph.1H423

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  110 in total

1.  Phenytoin toxicity in a patient receiving 5-fluorouracil-based chemotherapy for metastatic colorectal cancer.

Authors:  Sara M Kuruvilla; Som D Mukherjee
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  Phenytoin-induced reduction in sirolimus levels.

Authors:  Duane Bates; Kelly W Burak; Carla S Coffin; Tammy Ying; Echo-Marie Enns
Journal:  Can J Hosp Pharm       Date:  2011-07

3.  Interaction between amorolfine and acenocoumarol.

Authors:  José A Morales-Molina; Anna Fayet-Pérez; Enrique Martínez-Plata; Rosario Pérez-Moyano; M Angustias Molina-Arrebola
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

4.  A case of intention tremor induced by the combination of aripiprazole and lamotrigine.

Authors:  Rizwan Ali; Gagandeep Singh; Joseph W Iskandar; Kye Y Kim
Journal:  Prim Care Companion CNS Disord       Date:  2012-01-19

5.  The 'apparent clearance' of free phenytoin in elderly vs. younger adults.

Authors:  Daniel F B Wright; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

6.  Tacrolimus interaction with clotrimazole: a concise case report and literature review.

Authors:  Mary Choy
Journal:  P T       Date:  2010-10

7.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

Review 8.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

Review 9.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Toward a complete dataset of drug-drug interaction information from publicly available sources.

Authors:  Serkan Ayvaz; John Horn; Oktie Hassanzadeh; Qian Zhu; Johann Stan; Nicholas P Tatonetti; Santiago Vilar; Mathias Brochhausen; Matthias Samwald; Majid Rastegar-Mojarad; Michel Dumontier; Richard D Boyce
Journal:  J Biomed Inform       Date:  2015-04-24       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.